Thomas Fréret

5.8k total citations · 1 hit paper
123 papers, 4.4k citations indexed

About

Thomas Fréret is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Thomas Fréret has authored 123 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cellular and Molecular Neuroscience, 32 papers in Cognitive Neuroscience and 28 papers in Molecular Biology. Recurrent topics in Thomas Fréret's work include Neuroscience and Neuropharmacology Research (28 papers), Memory and Neural Mechanisms (24 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Thomas Fréret is often cited by papers focused on Neuroscience and Neuropharmacology Research (28 papers), Memory and Neural Mechanisms (24 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Thomas Fréret collaborates with scholars based in France, United States and Netherlands. Thomas Fréret's co-authors include Michel Boulouard, Pascale Schumann‐Bard, Valentine Bouët, Marianne Léger, Anne Quiedeville, Benoît Haelewyn, Didier Divoux, Myriam Bernaudin, Jérôme Toutain and Aurel Popa‐Wagner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Thomas Fréret

114 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Object recognition test in mice

2013 894 citations Marianne Léger, Valentine Bouët et al. profile →

Peers

Countries citing papers authored by Thomas Fréret

Since Specialization

Citations

This map shows the geographic impact of Thomas Fréret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fréret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fréret more than expected).

Fields of papers citing papers by Thomas Fréret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Fréret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fréret. The network helps show where Thomas Fréret may publish in the future.

Co-authorship network of co-authors of Thomas Fréret

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Fréret. A scholar is included among the top collaborators of Thomas Fréret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Fréret. Thomas Fréret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in Low-Dose Aspirin Use After Updated Guidance on Sociodemographic Risk Factors for Preeclampsia 2025 ·PubMed ·Thomas Fréret, Allison Bryant, Kaitlyn James, Anjali J. Kaimal, Alexander Melamed, Mark A. Clapp	0
2	Bilateral vestibulopathy affects spatial and temporal perception 2025 ·PLoS ONE ·(unknown), (unknown), (unknown), Scott J. Wood, Michel Toupet, Charlotte Hautefort, Christian Van Nechel, (unknown), (unknown), Thomas Fréret, Gaëlle Quarck, Pierre Denise, Gilles Clément	0
3	The 3-hit animal models of schizophrenia: Improving strategy to decipher and treat the disease? 2024 ·Neuroscience & Biobehavioral Reviews ·(unknown), (unknown), Jean‐Marie Billard, Thomas Fréret, Michel Boulouard, Valentine Bouët	5
4	Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease 2024 ·European Journal of Medicinal Chemistry ·Christophe Rochais, Cédric Lecoutey, (unknown), Audrey Davis, (unknown), Florence Gaven, (unknown), (unknown), Sophie Corvaisier, Jana Sopková‐de Oliveira Santos, Marc Since, Thomas Fréret, Romain Legrand, Noëlle Callizot, Sylvie Claeysen, Michel Boulouard, Patrick Dallemagne	0
5	Increased Rates of Hypertensive Disorders of Pregnancy during the COVID-19 Pandemic 2024 ·American Journal of Perinatology ·(unknown), Thomas Fréret, Mark A. Clapp, Sarah E Little	1
6	450 Changes in low-dose aspirin use after updated USPSTF and ACOG guidance on race 2024 ·American Journal of Obstetrics and Gynecology ·Thomas Fréret, (unknown), Kaitlyn James, Anjali J. Kaimal, Alexander Melamed, Mark A. Clapp	0
7	A new 2-hit model combining serine racemase deletion and maternal separation displays behavioral and cognitive deficits associated with schizophrenia 2024 ·Behavioural Brain Research ·(unknown), Michel Boulouard, (unknown), Thomas Fréret, Jean‐Marie Billard, (unknown)	2
8	A Dual-Task Paradigm Combining Physical and Cognitive Training in Mice: Application to Aging 2024 ·Aging and Disease ·(unknown), (unknown), Marianne Léger, (unknown), (unknown), (unknown), (unknown), Chantal Chavoix, Pascale Schumann‐Bard, Thomas Fréret	1
9	Core body temperature varies according to the time of exercise without affecting orexin-A production in the dorsal hypothalamus in male rats 2023 ·Journal of Thermal Biology ·(unknown), Tristan Martin, (unknown), Jan Bulla, (unknown), Valentine Bouët, Thomas Fréret, Karim Boumédiene, (unknown), Sébastien Moussay, François Dauphin, Nicolas Bessot	1
10	Chronotype influence on the effects of COVID‐19 lockdown on sleep and psychological status in France 2023 ·Journal of Sleep Research ·Nicolas Bessot, Antoine Langeard, Fabrice Dosseville, Gaëlle Quarck, Thomas Fréret	3
11	Genetic Background Influence on Hippocampal Synaptic Plasticity: Frequency-Dependent Variations between an Inbred and an Outbred Mice Strain 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Jean‐Marie Billard, (unknown), Marianne Léger, Pascale Schumann‐Bard, Thomas Fréret	1
12	5-HT6 Receptors Sex-Dependently Modulate Hippocampal Synaptic Activity through GABA Inhibition 2023 ·Biomolecules ·(unknown), Jean‐Marie Billard, Thomas Fréret, Valentine Bouët	3
13	Memory Disorders Related to Hippocampal Function: The Interest of 5-HT4Rs Targeting 2021 ·International Journal of Molecular Sciences ·(unknown), Marianne Léger, Thomas Fréret	15
14	Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer’s disease 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Cédric Lecoutey, Audrey Davis, Marc Since, Sophie Corvaisier, Thomas Fréret, Jana Sopková‐de Oliveira Santos, Sylvie Claeysen, Michel Boulouard, Patrick Dallemagne, Christophe Rochais	25
15	Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease 2019 ·Molecules ·(unknown), Cédric Lecoutey, (unknown), (unknown), Audrey Davis, Marc Since, Sophie Corvaisier, Thomas Fréret, Jana Sopková‐de Oliveira Santos, Sylvie Claeysen, Michel Boulouard, Patrick Dallemagne, Christophe Rochais	20
16	Donecopride, a Swiss army knife with potential against Alzheimer's disease 2019 ·British Journal of Pharmacology ·Christophe Rochais, Cédric Lecoutey, (unknown), Patrizia Giannoni, Florence Gaven, (unknown), Serge Mignani, Kévin Baranger, Thomas Fréret, Joël Bockaert, Santiago Rivera, Michel Boulouard, Patrick Dallemagne, Sylvie Claeysen	27
17	Genomic transcriptional profiling in LOU/C/Jall rats identifies genes for successful aging 2012 ·Brain Structure and Function ·Véronique Paban, Jean‐Marie Billard, Valentine Bouët, Thomas Fréret, Michel Boulouard, Caroline Chambon, Béatrice Loriod, Béatrice Alescio‐Lautier	11
18	Post‐stroke depression: mechanisms, translation and therapy 2012 ·Journal of Cellular and Molecular Medicine ·Isabelle Loubinoux, Golo Kronenberg, Matthias Endres, Pascale Schumann‐Bard, Thomas Fréret, Robert K. Filipkowski, Leszek Kaczmarek, Aurel Popa‐Wagner	248
19	Long-term functional outcome following transient middle cerebral artery occlusion in the rat: Correlation between brain damage and behavioral impairment. 2006 ·Behavioral Neuroscience ·Thomas Fréret, Laurent Chazalviel, Simon Roussel, Myriam Bernaudin, Pascale Schumann‐Bard, Michel Boulouard	62
20	Synthesis and preliminaryin vivoevaluation of new 2-Aryl-6-methyl-1,2-dihydro-1H-pyridin-4-ones and 2-Aryl-6-methylpiperidin-4-ols, as potential anti-amnesiant agents 2005 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), Thomas Fréret, Michel Boulouard, Patrick Dallemagne, Sylvain Rault	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact